Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

This study has been completed.
Human Genome Sciences Inc.
Information provided by (Responsible Party):
A.K.L. Reyners, University Medical Centre Groningen Identifier:
First received: March 10, 2010
Last updated: April 21, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)